In the Fall edition of the Biopharmaceutical Report we start from the importance of reliable software for statistical analyses, in particular in the pharmaceutical industry. We explain that the increase in using open source software is increasing the criticality of this topic, and summarize the progress that has been made by different initiatives around R in particular. Finally we motivate the creation of our new working group with the fact that little attention seems to have been devoted to good software engineering in biostatistics.
Read the full article on pages 61 and 62 of the Biopharmaceutical Report and let us know if you have any comments or feedback - we would love to hear from you!